SC 13G/A | 2022-02-14 | STATE STREET CORP | PFIZER INC | - | 5.1% | EDGAR |
SC 13G | 2022-02-14 | PFIZER INC | eFFECTOR Therapeutics, Inc. | 2,243,850 | 5.6% | EDGAR |
SC 13G/A | 2022-02-11 | PFIZER INC | 4D Molecular Therapeutics Inc. | 341,658 | 1.1% | EDGAR |
SC 13G/A | 2022-02-11 | PFIZER INC | Wave Life Sciences Ltd. | 1,875,000 | 3.2% | EDGAR |
SC 13G/A | 2022-02-11 | PFIZER INC | BioAtla, Inc. | 1,372,052 | 3.9% | EDGAR |
SC 13G/A | 2022-02-11 | PFIZER INC | ESSA Pharma Inc. | 1,675,000 | 3.8% | EDGAR |
SC 13G | 2022-02-11 | PFIZER INC | Pyxis Oncology, Inc. | 2,991,522 | 9.1% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | PFIZER INC | 465,274,925 | 8.3% | EDGAR |
SC 13G/A | 2022-02-01 | BlackRock Inc. | PFIZER INC | 409,985,645 | 7.3% | EDGAR |
SC 13G | 2021-11-19 | PFIZER INC | Cardiff Oncology, Inc. | 2,411,575 | 5.8% | EDGAR |
SC 13G | 2021-09-20 | PFIZER INC | ARVINAS, INC. | 3,457,815 | 6.6% | EDGAR |
SC 13D/A | 2021-09-17 | PFIZER INC | Allogene Therapeutics, Inc. | 22,032,040 | 15.5% | EDGAR |
SC 13D/A | 2021-09-17 | PFIZER INC | Cerevel Therapeutics Holdings, Inc. | 27,349,211 | 18.9% | EDGAR |
SC 13D/A | 2021-07-09 | PFIZER INC | Cerevel Therapeutics Holdings, Inc. | 27,349,211 | 19.4% | EDGAR |
SC 13G | 2021-07-09 | PFIZER INC | Spero Therapeutics, Inc. | 2,362,348 | 7.4% | EDGAR |
SC 13G/A | 2021-03-25 | PFIZER INC | Cortexyme, Inc. | 2,056,377 | 7.0% | EDGAR |
SC 13G/A | 2021-02-16 | PFIZER INC | Cortexyme, Inc. | 2,143,372 | 7.3% | EDGAR |
SC 13G | 2021-02-16 | PFIZER INC | BioAtla, Inc. | 2,238,090 | 7.0% | EDGAR |
SC 13G | 2021-02-16 | PFIZER INC | 4D Molecular Therapeutics Inc. | 1,666,658 | 6.3% | EDGAR |
SC 13G/A | 2021-02-12 | PFIZER INC | Mersana Therapeutics, Inc. | 0 | 0.0% | EDGAR |